Andrew H. Briggs

Has grant

London School of Hygiene & Tropical Medicine
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Quality-of-life in patients with long COVID: harnessing the scale of big data to quantify the health and economic costs

Open Date: 2021-08-01

Close Date: 2023-10-31

Grant: Close

UK evaluation of NHS support post-hospitalisation for COVID19 to inform service development and achieve holistic, integrated, equitable and cost-effective services

Open Date: 2021-06-01

Close Date: 2022-08-31

Grant: Close

A person-centred Needs Informed model of Care for people with HIV (NICHE), to improve wellbeing, mental health and reduce socio-economic disadvantages and stigma.

Open Date: 2021-05-01

Close Date: 2026-04-30

Grant: Close

Glasgow Molecular Pathology (GMP) Node

Open Date: 2015-11-01

Close Date: 2019-10-31

Grant: Close

Glasgow Clinical Research Facility: translating research into benefits for patients.

Open Date: 2015-07-01

Close Date: 2016-03-31

Articles (23)

Year:

2026

Year:

2026

Background Young people’s mental health worsened during and since the coronavirus disease discovered in 2019 pandemic. School environments play a key role in young people’s mental health. Learning Together for Mental Health is a whole-school intervention aiming to promote mental health in secondary schools, adapted from the previous Learning Together intervention which was found effective in reducing bullying and promoting mental health. Objective To adapt Learning Together to increase focus on mental health so producing the Learning Together for Mental Health intervention and evaluate the appropriateness of conducting a Phase III trial of the Learning Together for Mental Health intervention regarding pre-defined progression criteria relating to the intervention and trial methods, and assessing intervention feasibility, reach and acceptability, feasibility of trial measures and procedures, potential mechanisms and possible harms. Design and methods We conducted a feasibility study with baseline and follow-up surveys, process evaluation and economic-evaluation feasibility-testing. Setting and participants One school participated in intervention adaptation. Our feasibility study included four state, mixed-sex secondary schools in southern England (one of which dropped out after baselines and was replaced with another). We recruited 640 year-7 (age 11–12) students at baseline survey and 566 year-10 (age 14–15) students at 12-month follow-up. Baseline and follow-up participants were different groups, as the focus was assessing feasibility for the age groups to be surveyed at baseline and follow-up in a Phase III randomised controlled trial. Twenty staff, 27 year-8 (age 12–13) students and 22 year-10 students participated in qualitative research as did two trainers and one external facilitator. Interventions As part of our feasibility study, all schools received the Learning Together for Mental Health intervention for one academic school year. Main outcome measures Pre-defined criteria for progression to a Phase III trial. Results The intervention was successfully adapted from the previous intervention using public involvement. The trial met all criteria for progression to Phase III. The all-staff and in-depth restorative practice training were implemented with fidelity in all schools and all schools had at least two staff trained in-depth in restorative practice. Curriculum training was delivered with fidelity in three of four schools. The response rate to the baseline (needs) survey across the three participating schools was 79%. Progression required at least two schools to have delivered the curriculum with at least 50% fidelity, which was achieved; one of the two schools which delivered the curriculum reported over 80% fidelity and the other school reported over 75% fidelity. All students and staff across all four schools who completed the action group survey and 93% of senior leadership team members who completed the senior leadership team survey reported that Learning Together for mental health was a good way to promote student Mental Health. Potential mechanisms of action involve promoting student sense of school belonging and practical reasoning and skills. No harms were reported. Trial measures and procedures were feasible and acceptable to implement. Intervention and trial refinement are suggested. Limitations Our study involved a small, purposive sample of schools and students which are not representative of those in England. Conclusions With some minor amendments, Learning Together for Mental Health should be subject to a future Phase III trial of effectiveness. Future work The intervention should be refined by making the curriculum optional and improving materials. Funding This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme as award number NIHR131594.

Year:

2026

Year:

2026

Year:

2026

Adjuvant chemotherapy for colorectal cancer (CRC) with oxaliplatin and fluoropyrimidine was traditionally given for 6 months but is associated with cumulative peripheral neuropathy. The SCOT study (ISRCTN59757862) was an international, randomized, phase III, noninferiority trial investigating treatment reduction from 6 to 3 months. It originally reported noninferior disease-free survival with reduced toxicity and improved quality of life for 3 months of treatment in 6,088 patients. Here, we report overall survival (OS) with 38 months of additional follow-up. Patients with high-risk stage II and stage III CRC were assigned (1:1) to receive 3 or 6 months of either capecitabine and oxaliplatin (CAPOX) or infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX; bolus and infused fluorouracil with oxaliplatin) that were selected before random assignment. With a median of 113 months follow-up and 1,255 OS events, 5-year OS for 3 versus 6 months of treatment was 82.4% in both groups (hazard ratio, 0.96; 95% CI, 0.8 to 1.07), proving noninferiority of 3 months of treatment. Noninferiority of 3 months of treatment for OS was also shown in 1,087 patients with rectal cancer. The duration effect is regimen-dependent with noninferiority shown for CAPOX but not for FOLFOX. In summary, SCOT has shown noninferiority for OS with 3 months of adjuvant chemotherapy treatment, which should be recommended for most patients.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2022

Collaborators (54)

Maria Sofia Massa

University of Oxford

UNITED KINGDOM
View details

Manuela Deidda

University of Glasgow

UNITED KINGDOM
View details

Steven Hope

University College London

UNITED KINGDOM
View details

Jagpreet Chhatwal

Assistant Professor

Harvard Medical School

UNITED STATES
View details

Jeremy Brown

University College London

UNITED KINGDOM
View details

chris brightling

Professor and Honorary Consultant

University of Leicester

UNITED KINGDOM
View details

Simon Heller

Professor of Clinical Diabetes

University of Sheffield

UNITED KINGDOM
View details

Trudie Chalder

King’s College London

UNITED KINGDOM
View details

Nazir I Lone

Professor

University of Edinburgh

UNITED KINGDOM
View details

Csaba P. Kovesdy

-

UNITED STATES
View details

Rachael Evans

Professor of Respiratory Medicine

University of Leicester

UNITED KINGDOM
View details

Jose Robles-Zurita

PROFESOR PERMANENTE LABORAL

University of Malaga

SPAIN
View details

Hamish McAuley

Academic Clinical Lecturer

University of Leicester

UNITED KINGDOM
View details

Amanda Adler

University of Oxford

UNITED KINGDOM
View details

Pilar Rivera-Ortega

Associate Research and Development Director

Manchester University NHS Foundation Trust

UNITED KINGDOM
View details

Anirban Basu

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Sharon B Love

Methodology Lead of Trial Conduct Research

University College London

UNITED KINGDOM
View details

Aris Angelis

Assistant Professor in Health Economics

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

john ramage

Professor

King’s College London

UNITED KINGDOM
View details

Caroline Jolley

Reader in Respiratory Medicine & Physiology

King’s College London

UNITED KINGDOM
View details

Neisha Sundaram

Assistant Professor

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Malcolm Gracie Semple

Professor of Outbreak Medicine and Child Health

University of Liverpool

UNITED KINGDOM
View details

Charlotte Bolton

Professor of Respiratory Medicine

University of Nottingham

UNITED KINGDOM
View details

Julio Garcia-Aguilar

Chief Attending Surgeon, Colorectal Service

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Stephen O'Neill

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Pardeep Jhund

University of Glasgow

UNITED KINGDOM
View details

Adrian Levy

Professor and Head

Dalhousie University

CANADA
View details

rosa legood

Associate Professor

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Caroline Kelly

Head of Biostatistics

-

UNITED KINGDOM
View details

Josep Tabernero

Associate Professor Faculty of Medicine

Universitat de Vic - Universitat Central de Catalunya

SPAIN
View details

Hongtu Zhu

University of North Carolina

UNITED STATES
View details

Dasha Nicholls

Clinical and Strategic Director, National Audits and Research

Imperial College London

UNITED KINGDOM
View details

Ewen Harrison

Director. Professor of Surgery and Data Science. Consultant Surgeon

University of Edinburgh

UNITED KINGDOM
View details

David G Lugo-Palacios

Assistant Professor

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

J. Wouter Jukema

Leiden University Medical Center

NETHERLANDS
View details

Neil Greening

NIHR Post-Doctoral Fellow, Associate Professor (Clinical)/Honorary Consultant Physician

University of Leicester

UNITED KINGDOM
View details

Frank Sullivan

Professor of Primary Care Medicine

University of St. Andrews

UNITED KINGDOM
View details

Frances Mair

Professor

University of Glasgow

UNITED KINGDOM
View details

Philippe Gabriel Steg

Assistance Publique - Hôpitaux de Paris

FRANCE
View details

Annemarie Docherty

Senior Clinical Lecturer/Intensive Care Consultant

University of Edinburgh

UNITED KINGDOM
View details

Martin Cowie

Imperial College London

UNITED KINGDOM
View details

Joanna Porter

University College London

UNITED KINGDOM
View details

Anna Carnegie

King’s College London

UNITED KINGDOM
View details

Richard Silverwood

University College London

UNITED KINGDOM
View details

Ciaran Kohli-Lynch

Assistant Professor

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Mark Jones

Professor of Respiratory Medicine

University of Southampton

UNITED KINGDOM
View details

Ali S Taha

University Hospital

UNITED KINGDOM
View details

Dan Wootton

Senior Clinical Lecturer

University of Liverpool

UNITED KINGDOM
View details

Ashish Deshmukh

Professor

Medical University of South Carolina

UNITED STATES
View details

Elizabeth Allen

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

David Cunningham

Professor Cancer Medicine

Institute of Cancer Research

UNITED KINGDOM
View details

Jonathan Fuld

National Clinical Director for Respiratory

NHS England

UNITED KINGDOM
View details

Nicola McMeekin

Research Associate

University of Glasgow

UNITED KINGDOM
View details

Olivia Leavy

University of Leicester

UNITED KINGDOM
View details